The abrogation of TPL2-mediated PSA promoter activation in AR-negative DU-145 prostate cancer cells suggests that TPL2-mediated ADI prostate cancer growth may be still dependent on AR activity. This evidence concerns the gene KLK3 and Familial prostate cancer.